Discontinuation of continuous renal replacement therapy: A post hoc analysis of a prospective multicenter observational study
Autor: | Miet Schetz, Catherine S. C. Bouman, John A. Kellum, Hiroshi Morimatsu, Ian K S Tan, Rinaldo Bellomo, Etienne Macedo, Shigehiko Uchino, Stanislo Morgera, Claudio Ronco, Noel Gibney, Heleen M. Oudemans-van Straaten, Ashita Tolwani |
---|---|
Přispěvatelé: | AII - Amsterdam institute for Infection and Immunity, Intensive Care Medicine |
Jazyk: | angličtina |
Rok vydání: | 2009 |
Předmět: |
medicine.medical_specialty
Creatinine business.industry medicine.medical_treatment Critical Care and Intensive Care Medicine medicine.disease Surgery Discontinuation chemistry.chemical_compound chemistry Intensive care Internal medicine Post-hoc analysis Hemofiltration medicine Renal replacement therapy Prospective cohort study business Kidney disease |
Zdroj: | Critical care medicine, 37(9), 2576-2582. Lippincott Williams and Wilkins |
ISSN: | 0090-3493 |
Popis: | Objectives: To describe current practice for the discontinuation of continuous renal replacement therapy in a multinational setting and to identify variables associated with successful discontinuation. The approach to discontinue continuous renal replacement therapy may affect patient outcomes. However, there is lack of information on how and under what conditions continuous renal replacement therapy is discontinued. Design: Post hoc analysis of a prospective observational study. Setting. Fifty-four intensive care units in 23 countries. Patients: Five hundred twenty-nine patients (52.6%) who survived initial therapy among 1006 patients treated with continuous renal replacement therapy. Interventions: None. Measurements and Main Results., Three hundred thirteen patients were removed successfully from continuous renal replacement therapy and did not require any renal replacement therapy for at least 7 days and were classified as the "success" group and the rest (216 patients) were classified as the "repeat-RRT" (renal replacement therapy) group. Patients in the "success" group had lower hospital mortality (28.5% vs. 42.7%, p |
Databáze: | OpenAIRE |
Externí odkaz: |